2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Pathological Myopia: new trials by email Literature Review of Pathological Myopia trials Research Report on Pathological Myopia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy ranibizumab injection (0.5 mg) - Coats' Disease, Idiopathic Retinal Telangiectasia | Phase 1 / Phase 2 | Completed | Manhattan Eye, Ear & Throat Hospital | 18 | 2007-05-01 | 2012-10-25 |
| Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD) Bevacizumab - Choroidal Neovascularization, Degenerative Myopia | Phase 1 | Completed | Johns Hopkins University | 10 | 2005-06-01 | 2009-02-03 |
Myopia, Degenerative (2) · Choroidal Neovascularization (1) · Polypoidal Choroidal Vasculopathy (1) · Pseudoxanthoma Elasticum (1) · Retinal Telangiectasis (1) · Vitelliform Macular Dystrophy (1) · von Hippel-Lindau Disease (1)
Choroid Diseases (2) · Eye Diseases (2) · Metaplasia (2) · Myopia (2) · Neovascularization, Pathologic (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Refractive Errors (2) · Uveal Diseases (2) · Abnormalities, Multiple (1) · Angiomatosis (1) · Cardiovascular Diseases (1) · Choroidal Neovascularization (1) · Ciliopathies (1) · Congenital Abnormalities (1)
Bevacizumab (1) · Ranibizumab (1)
Johns Hopkins University (1) · Manhattan Eye, Ear & Throat Hospital (1)
United States (1)
Lawrence A. Yannuzzi, MD (1) · Quan D Nguyen, MD, MSc (1)